Skip to main content
Supplement ScienceSupplementScience

Echinacea Side Effects & Safety

Evidence:Moderate
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Safety Profile

Overall safety rating: Generally Safe

Potential Side Effects

  • Generally well-tolerated with an excellent safety profile
  • Mild GI symptoms (nausea, stomach pain) in some users
  • Allergic reactions possible in individuals allergic to plants in the daisy (Asteraceae) family
  • Rare: skin rash, itching, or worsening of asthma symptoms

Drug & Supplement Interactions

  • Immunosuppressants — echinacea stimulates immune function and may counteract immunosuppressive medications
  • CYP3A4 substrates — some evidence echinacea modestly inhibits CYP3A4; potential interaction with medications metabolized by this enzyme
  • Caffeine — echinacea may slow caffeine clearance; minor clinical significance

Maximum Dose

Do not exceed: No established upper limit; typically used for 8-12 week courses rather than year-round

References

  1. Meta-analysisShah SA, Sander S, White CM, Rinaldi M, Coleman CI (2007). Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. The Lancet Infectious Diseases. DOI PubMed
  2. Meta-analysisKarsch-Volk M, Barrett B, Kiefer D, Bauer R, Ardjomand-Woelkart K, Linde K (2014). Echinacea for preventing and treating the common cold. Cochrane Database of Systematic Reviews. DOI PubMed
  3. Meta-analysisPham TP, Vu TM, Doan PM, Nguyen TT, et al. (2025). Efficacy and safety of Echinacea purpurea in treating upper respiratory infections and complications of otitis media in children: Systematic review and meta-analysis.. Clinical nutrition ESPEN. DOI PubMed
  4. Meta-analysisDeccy S, Bartkowiak C, Rodricks N, Paultre K (2024). Echinacea Supplementation Does Not Impact Aerobic Capacity and Erythropoiesis in Athletes: A Meta-Analysis.. Nutrients. DOI PubMed
  5. Meta-analysisDavid S, Cunningham R (2019). Echinacea for the prevention and treatment of upper respiratory tract infections: A systematic review and meta-analysis.. Complementary therapies in medicine. DOI PubMed
  6. Schoop R, Klein P, Suter A, Johnston SL (2006). Echinacea in the prevention of induced rhinovirus colds: a meta-analysis.. Clinical therapeutics. DOI PubMed
  7. Linde K, Barrett B, Wölkart K, Bauer R, et al. (2006). Echinacea for preventing and treating the common cold.. The Cochrane database of systematic reviews. DOI PubMed
Show 5 more references
  1. Gillespie EL, Coleman CI (2006). The effect of Echinacea on upper respiratory infection symptom severity and quality of life.. Connecticut medicine. PubMed
  2. Ernst E (2002). The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava.. Annals of internal medicine. DOI PubMed
  3. Huntley AL, Thompson Coon J, Ernst E (2005). The safety of herbal medicinal products derived from Echinacea species: a systematic review.. Drug safety. DOI PubMed
  4. Basch E, Ulbricht C, Basch S, Dalton S, et al. (2005). An evidence-based systemic review Echinacea E. angustifolia DC, E. pallida, E. purpurea by the Natural Standard Research Collaboration.. Journal of herbal pharmacotherapy. PubMed
  5. Melchart D, Linde K, Fischer P, Kaesmayr J (2000). Echinacea for preventing and treating the common cold.. The Cochrane database of systematic reviews. DOI PubMed